Lab / USD 200M JV between Prenetics and CUHK's Prof. Dennis Lo for multi-cancer early detection; largest private life sciences deal in Hong Kong history
Insighta
Insighta is a USD 200 million joint venture established in 2023 between Prenetics Global and Prof. Dennis Lo of CUHK, headquartered at Hong Kong Science and Technology Park. It is commercializing Presight, a multi-cancer early detection blood test initially focused on liver and lung cancer, with commercial launch in Hong Kong and mainland China targeted for 2025, and a multi-cancer (10-plus) version planned for 2027. This is described as the largest private life sciences deal in Hong Kong history.
Relationships
Prenetics Group
Prenetics (NASDAQ: PRE); CUHK Li Ka Shing Institute of Health Sciences
Prenetics / CircleDNA, Prenetics / CircleDNA
Key people
- Prof. Dennis Lo (Chairman, inventor of cell-free DNA diagnostics); Danny Yeung (CEO)